SEC FORM 4
$0.00
Iambic Therapeutics, Inc. (IAM)
Acquisition (code A) of 28,400 shares at $0 per share.
Reporting Person Secora Michael · Officer Title CFO & Chief Corp Dev Ofcr · Transaction Code A
Traded Oct 14, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001855980-26-000007 · filed 2026-10-16 · View filing →